Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
24 vs 72 Hours of Terlipressin in Acute Variceal Bleed
NCT00369694Phase 4Completed
- Sponsor
- Aga Khan University
- Start
- Aug 2006
- Primary completion
- Jul 2008
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of terlipressin in Esophageal variceal hemorrhage (EVH) (2 arms), sponsored by Aga Khan University. Primary endpoint: Variceal Re-bleed at 120 hours. Started Aug 2006; status: completed.
02
Drugs
terlipressin
03
Conditions
Esophageal variceal hemorrhage (EVH)
Beyond the preview
Go deeper on NCT00369694.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00369694.